Novartis Everolimus Transition

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Graft DysfunctionInterstitial Fibrosis
Interventions
DRUG

Everolimus

Convert mycophenolate to everolimus with subsequent reduction in exposure to tacrolimus

OTHER

Standard of Care

Tacrolimus, mycophenolate mofetil and steroids

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Medical University of South Carolina

OTHER